Suppr超能文献

子宫内膜样腺癌的手术分期:斯里兰卡一家妇科癌症中心的术后结果分析

Surgical Staging of Differentiated Endometrial Cancer: An Analysis of Postoperative Outcome in a Gynecological Cancer Center in Sri Lanka.

作者信息

Wijesinghe Rajitha D, Patabendige Malitha, Pakthagunanathan Nishanthi, Hapuachchige Chintana

机构信息

Gynecological Oncology, Teaching Hospital Mahamodara, Galle, LKA.

Obstetrics and Gynaecology, Base Hospital, Mahaoya, Mahaoya, LKA.

出版信息

Cureus. 2023 Jul 9;15(7):e41605. doi: 10.7759/cureus.41605. eCollection 2023 Jul.

Abstract

INTRODUCTION

Even though surgico-pathological staging is recommended in poorly differentiated endometrial cancer, management of differentiated endometrial cancer is controversial. Preoperative pelvic and abdominal Magnetic Resonance Imaging (MRI) is recommended in well-differentiated endometrial cancer to identify patients with risk factors for regional metastasis. However, access to MRI is limited in Sri Lanka, and surgico-pathological staging is the primary staging method available for most patients with differentiated endometrial cancer. Our objective was to evaluate the outcome of surgical staging among differentiated endometrial cancer patients who underwent primary surgery at the gynecological cancer center of Apeksha Hospital Maharagama, Sri Lanka.

METHODS

A retrospective study was conducted using the ongoing electronic database at the gynecological cancer center of the National Cancer Institute (Apeksha Hospital) in Maharagama, Sri Lanka. Data from December 2019 to December 2020 were selected for analysis.

RESULTS

During the study period, 112 patients with endometrial cancer underwent hysterectomy. This study included 90 patients with differentiated endometrial cancer (International Federation of Gynecology and Obstetrics [FIGO] Grade 1 and Grade 2), out of which pelvic lymph node dissection was performed in 78 (86.7%) cases. Among the 90 patients, 54 (60%) had medical comorbidities. It was reported that 35% (n=32) of the patients had myometrial invasion of more than 50% thickness. Furthermore, 13.8% of patients with deep myometrial invasion had lymph node metastasis, while only one patient (2%) in the superficial or no myometrial invasion group had lymph node metastasis. Therefore, the absence of deep myometrial invasion has a negative predictive value of around 98% for excluding pelvic lymph node metastasis.

CONCLUSION

Approximately one in seven patients with deeply infiltrating differentiated endometrial cancer had lymph node metastasis. In limited resource settings where preoperative pelvic MRI is not readily available, implementing a policy of routine surgical pelvic lymph node assessment would be beneficial. This approach would aid in detecting stage IIIc disease and also help avoid unnecessary pelvic irradiation.

摘要

引言

尽管对于低分化子宫内膜癌推荐采用外科病理分期,但高分化子宫内膜癌的治疗仍存在争议。对于高分化子宫内膜癌,建议术前行盆腔和腹部磁共振成像(MRI)以识别有区域转移风险因素的患者。然而,在斯里兰卡,MRI的可及性有限,对于大多数高分化子宫内膜癌患者,外科病理分期是主要可用的分期方法。我们的目的是评估在斯里兰卡马哈拉加马阿佩克沙医院妇科癌症中心接受初次手术的高分化子宫内膜癌患者的手术分期结果。

方法

使用斯里兰卡马哈拉加马国家癌症研究所(阿佩克沙医院)妇科癌症中心正在使用的电子数据库进行了一项回顾性研究。选取2019年12月至2020年12月的数据进行分析。

结果

在研究期间,112例子宫内膜癌患者接受了子宫切除术。本研究纳入了90例高分化子宫内膜癌患者(国际妇产科联盟[FIGO]1级和2级),其中78例(86.7%)进行了盆腔淋巴结清扫。在这90例患者中,54例(60%)有内科合并症。据报告,35%(n = 32)的患者肌层浸润超过50%厚度。此外,肌层深部浸润患者中有13.8%发生淋巴结转移,而肌层浅部浸润或无肌层浸润组中只有1例患者(2%)发生淋巴结转移。因此,无肌层深部浸润对于排除盆腔淋巴结转移的阴性预测值约为98%。

结论

大约七分之一的高分化子宫内膜癌深部浸润患者有淋巴结转移。在术前盆腔MRI不易获得的资源有限环境中,实施常规手术盆腔淋巴结评估政策将是有益的。这种方法将有助于检测Ⅲc期疾病,也有助于避免不必要的盆腔放疗。

相似文献

9
The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.
Indian J Surg Oncol. 2014 Jun;5(2):109-14. doi: 10.1007/s13193-014-0303-x. Epub 2014 Mar 28.
10
Prediction of lymph node metastasis in patients with apparent early endometrial cancer.
Obstet Gynecol Sci. 2015 Sep;58(5):385-90. doi: 10.5468/ogs.2015.58.5.385. Epub 2015 Sep 22.

本文引用的文献

1
Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019.
Gynecol Oncol. 2021 May;161(2):573-580. doi: 10.1016/j.ygyno.2021.01.036. Epub 2021 Feb 5.
2
3
Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI?
Arch Gynecol Obstet. 2020 Mar;301(3):737-744. doi: 10.1007/s00404-019-05418-z. Epub 2019 Dec 27.
4
Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study.
Cancer Causes Control. 2019 Apr;30(4):355-363. doi: 10.1007/s10552-019-01139-5. Epub 2019 Feb 20.
5
Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S93-S113. doi: 10.1097/PGP.0000000000000524.
6
Role of imaging in the routine management of endometrial cancer.
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2(Suppl 2):109-117. doi: 10.1002/ijgo.12618.
7
Cancer of the corpus uteri.
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:37-50. doi: 10.1002/ijgo.12612.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
BGCS uterine cancer guidelines: Recommendations for practice.
Eur J Obstet Gynecol Reprod Biol. 2017 Jun;213:71-97. doi: 10.1016/j.ejogrb.2017.04.015. Epub 2017 Apr 13.
10
Diagnosis and Management of Endometrial Cancer.
Am Fam Physician. 2016 Mar 15;93(6):468-74.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验